Emerge Venture Lab Ltd 08222113 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is that of a corporate venturing, mentoring and training business. Digita Accounts Production Advanced 6.30.9574.0 true false false 08222113 2024-01-01 2024-12-31 08222113 2024-12-31 08222113 bus:OrdinaryShareClass1 2024-12-31 08222113 bus:OrdinaryShareClass2 2024-12-31 08222113 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2024-12-31 08222113 core:CurrentFinancialInstruments 2024-12-31 08222113 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08222113 core:OtherPropertyPlantEquipment 2024-12-31 08222113 bus:SmallEntities 2024-01-01 2024-12-31 08222113 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08222113 bus:FilletedAccounts 2024-01-01 2024-12-31 08222113 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08222113 bus:RegisteredOffice 2024-01-01 2024-12-31 08222113 bus:Director3 2024-01-01 2024-12-31 08222113 bus:Director4 2024-01-01 2024-12-31 08222113 bus:Director5 2024-01-01 2024-12-31 08222113 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 08222113 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 08222113 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08222113 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 08222113 core:PlantMachinery 2024-01-01 2024-12-31 08222113 core:Subsidiary1 2024-01-01 2024-12-31 08222113 core:Subsidiary1 1 2024-01-01 2024-12-31 08222113 countries:England 2024-01-01 2024-12-31 08222113 2023-12-31 08222113 core:CostValuation 2023-12-31 08222113 core:OtherPropertyPlantEquipment 2023-12-31 08222113 2023-01-01 2023-12-31 08222113 2023-12-31 08222113 bus:OrdinaryShareClass1 2023-12-31 08222113 bus:OrdinaryShareClass2 2023-12-31 08222113 core:CurrentFinancialInstruments 2023-12-31 08222113 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 08222113 core:OtherPropertyPlantEquipment 2023-12-31 08222113 core:Subsidiary1 1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08222113

Emerge Venture Lab Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Emerge Venture Lab Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 9

 

Emerge Venture Lab Ltd

Company Information

Directors

J Matern

N Elstub

N Newman

Registered office

15 Emerge Education
Jisc, Fetter Lane
London
EC4A 1BW

 

Emerge Venture Lab Ltd

(Registration number: 08222113)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

3,998

8,349

Investments

5

1

1

Other financial assets

6

1,516,310

1,615,837

 

1,520,309

1,624,187

Current assets

 

Debtors

7

29,912

55,782

Cash at bank and in hand

 

237,506

325,509

 

267,418

381,291

Creditors: Amounts falling due within one year

8

(114,712)

(66,648)

Net current assets

 

152,706

314,643

Net assets

 

1,673,015

1,938,830

Capital and reserves

 

Called up share capital

6,117

6,117

Share premium reserve

925,396

925,396

Other reserves

(5,000)

(5,000)

Retained earnings

746,502

1,012,317

Shareholders' funds

 

1,673,015

1,938,830

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 9 September 2025 and signed on its behalf by:
 

 

Emerge Venture Lab Ltd

(Registration number: 08222113)
Balance Sheet as at 31 December 2024

.........................................
J Matern
Director

 

Emerge Venture Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
15 Emerge Education
Jisc, Fetter Lane
London
EC4A 1BW
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Emerge Venture Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

33% straight line basis

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.


Debtors receivable within one year
Debtors with no stated interest rate and receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
 

 

Emerge Venture Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.


Creditors payable within one year
Creditors with no stated interest rate and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
 

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 3).

 

Emerge Venture Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Tangible assets

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2024

31,852

31,852

Additions

995

995

At 31 December 2024

32,847

32,847

Depreciation

At 1 January 2024

23,503

23,503

Charge for the year

5,346

5,346

At 31 December 2024

28,849

28,849

Carrying amount

At 31 December 2024

3,998

3,998

At 31 December 2023

8,349

8,349

5

Investments

2024
£

2023
£

Investments in subsidiaries

1

1

Subsidiaries

£

Cost or valuation

At 1 January 2024

1

Carrying amount

At 31 December 2024

1

At 31 December 2023

1

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

 

Emerge Venture Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2024

2023

Subsidiary undertakings

Emerge Ventures Ltd

England and Wales

500000 Ordinary shares of £0.000001

50%

50%

Subsidiary undertakings

Emerge Ventures Ltd

The principal activity of Emerge Ventures Ltd is management consultancy activities other than financial management.

6

Other financial assets (current and non-current)

Financial assets

Non-current financial assets

Cost or valuation

At 1 January 2024

1,615,836

Fair value revaluations

(241,224)

Impairment write downs

(11,140)

Additions

152,838

At 31 December 2024

1,516,310

Carrying amount

At 31 December 2024

1,516,310

7

Debtors

Current

Note

2024
£

2023
£

Amounts owed by related parties

10

14,206

39,014

Prepayments

 

640

9,037

Other debtors

 

15,066

7,731

   

29,912

55,782

 

Emerge Venture Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

8

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Trade creditors

 

325

2,580

Amounts owed to group undertakings

10

24,213

-

Taxation and social security

 

-

5,289

Accruals and deferred income

 

-

23,967

Other creditors

 

90,174

34,812

 

114,712

66,648

9

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £0.001 each

60,054

60.05

60,054

60.05

Deferred shares of £0.001 each

6,056,810

6,056.81

6,056,810

6,056.81

 

6,116,864

6,116.86

6,116,864

6,116.86

10

Related party transactions

The Company has taken advantage of the exemption in Section 33.1 A of FRS 102 Related Party Transactions from disclosing transactions with other members of the Group.

11

Control

The Company is deemed to be controlled by the director, J Matern.

The ultimate controlling party is also deemed to be the director, J Matern.